UBS Group’s Themes US R&D Champions ETF USRD Stock Holding History

UBS Group’s Portfolio USRD Stock Details USRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3	Closed	-$100	–	11203
2025 Q4	$100	Hold	3	–	–	﹤0.01%	10189
2025 Q3	$100	Sell	3 -35	-92%	-$1.15K	﹤0.01%	9924
2025 Q2	$1.23K	Buy	38 +5	+15%	+$145	﹤0.01%	9656
2025 Q1	$911	Hold	33	–	–	﹤0.01%	9623
2024 Q4	$981	Buy	33 +30	+1,000%	+$939	﹤0.01%	9338
2024 Q3	$93	Buy	+3	New	+$89	﹤0.01%	9165

UBS Group's USRD Position: Q1 2026 in Review

UBS Group sold out of Themes US R&D Champions ETF (USRD) in Q1 2026, closing a stake of 3 shares — an estimated $100 sold.

UBS Group first reported a position in USRD in Q3 2024 and held it in 6 quarters. The position peaked at $1.23K in Q2 2025. 0 funds tracked by Wall St. Rank hold USRD as of Q1 2026.

UBS Group reported no remaining Themes US R&D Champions ETF position as of Q1 2026 after selling out during the quarter.
UBS Group sold 3 Themes US R&D Champions ETF shares in Q1 2026, an estimated $100.
UBS Group first reported a position in Themes US R&D Champions ETF in Q3 2024 and held it in 6 quarters.
UBS Group's Themes US R&D Champions ETF position peaked at $1.23K in Q2 2025.
0 funds tracked by Wall St. Rank held Themes US R&D Champions ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.